3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
51
Neoplasms
36
Lung Neoplasms
25
Colorectal Neoplasms
24
Prostatic Neoplasms
15
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Anxiety Disorders
9
Obesity
8
Lymphoma
8
Depression
8
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Melanoma
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Pain
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Smoking Cessation
4
Papillomavirus Infections
4
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Cisplatin
5
Docetaxel
4
Brachytherapy
4
Pemetrexed
3
Gemcitabine
3
Doxorubicin
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Letrozole
2
Immunoglobulin G
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Neoplasms
×
Methods
×
Clear all
NCT05939440
2025-06-05
P-COC
University of Alabama at Birmingham
Phase NA
Completed
60 enrolled